New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer ResearchAbout EVAXION Evaxion Biotech A/S is a pioneering TechBio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback